D-0402-2026 Class II Ongoing
FDA drug recall D-0402-2026 was initiated by Chiesi USA, Inc. on Mar 17, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 7,235 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 1, 2026
- Initiation Date
- Mar 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,235 vials
Product description
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide within the United States
Code information
Lot #: 1213748, Exp. Date 09/2026; 1215076, 1215077, Exp. Date 10/26.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0402-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026